About Interon Laboratories
Interon Laboratories is a company based in Newton (United States) founded in 2020 by Jun Huh. Interon Laboratories offers products and services including Neuro-Immunotherapy, Biologics Programs, and Small Molecule Therapeutics. Interon Laboratories operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Newton, United States
- Founders Jun Huh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Interon Laboratories
Interon Laboratories offers a comprehensive portfolio of products and services, including Neuro-Immunotherapy, Biologics Programs, and Small Molecule Therapeutics.
Combines neurobiology and immunology for non-invasive treatments.
Develops biologics to mitigate neurological disorders.
Targets immune disorders with innovative molecules.
People of Interon Laboratories
Unlock access to complete
Unlock access to complete
Funding Insights of Interon Laboratories
Investors in Interon Laboratories
Interon Laboratories has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Hanall Biopharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biopharmaceutical firm developing drugs for ophthalmology, immunology, oncology, and neurology.
|
Locked | Locked | Locked |
Investor details for Interon Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Interon Laboratories
Investment portfolio details for Interon Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Interon Laboratories
Detailed financials for Interon Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Interon Laboratories Comparisons
Peer comparison for Interon Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Interon Laboratories
Interon Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| Locked | Locked | Locked |
Small molecule drugs for rare diseases are developed.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
Detailed competitors of Interon Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Interon Laboratories
Complete news archive for Interon Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Interon Laboratories
Interon Laboratories was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Interon Laboratories is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
Interon Laboratories was founded in 2020 in Newton, United States, within the biotechnology sector. Focus is placed on biologics and small molecule therapeutics to address neurological and immune disorders. The neuro-immune axis pathway is modulated through these treatments. Operations center on research and development of immunotherapies, with potential applications in mitigating related conditions. Leadership includes co-founder Jun Huh.
Interon Laboratories's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
Interon Laboratories offers Neuro-Immunotherapy, Biologics Programs, and Small Molecule Therapeutics.
Interon Laboratories has 1 investor. Key investors include Hanall Biopharma.